View Older Stories View More Recent Stories

Mar 1, 2021 07:00AM Amicus Therapeutics Announces Full-Year 2020 Financial Results and Corporate Updates
Feb 18, 2021 07:00AM Amicus Therapeutics to Present at Upcoming Investor Conferences
Feb 17, 2021 07:00AM Amicus Therapeutics to Announce Full-Year 2020 Financial Results on March 1, 2021
Feb 11, 2021 04:02PM Amicus' (FOLD) AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase
Feb 11, 2021 04:01PM Amicus’ AT-GAA Shows Clinically Meaningful & Significant Improvements in Both Musculoskeletal and Respiratory Measures in Late-Onset Pompe Disease Compared to Standard of Care in Pivotal Phase 3
Feb 8, 2021 02:30PM Amicus Therapeutics (FOLD) Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium
Feb 8, 2021 02:30PM Amicus Therapeutics Presents Positive Preclinical Fabry Disease Gene Therapy Data at the 17th Annual WORLDSymposium™ 2021
Feb 8, 2021 02:30PM Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021
Jan 21, 2021 07:00AM Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
Jan 11, 2021 09:07AM Amicus Therapeutics (FOLD) Announces Prelim. FY20 Revenue Outlook Above Consensus
Jan 11, 2021 07:00AM Amicus Therapeutics Reports Preliminary 2020 Revenue and Provides 2021 Outlook
Jan 5, 2021 07:00AM Amicus Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 7, 2020 07:00AM Amicus Therapeutics Named a Great Place to Work-Certified™ Company in 2020
Dec 2, 2020 07:00AM Amicus Therapeutics Appoints Michael A. Kelly to its Board of Directors
Dec 1, 2020 07:03AM Amicus Therapeutics (FOLD) Initiates Rolling BLA to FDA for AT-GAA in Late-Onset Pompe Disease
Dec 1, 2020 07:00AM Amicus Therapeutics Initiates Rolling Biologic License Application to the U.S. Food and Drug Administration for AT-GAA in Late-Onset Pompe Disease
Nov 23, 2020 07:00AM Amicus Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference
Nov 5, 2020 07:00AM Amicus Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates
Nov 2, 2020 07:00AM Amicus Therapeutics to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
Oct 22, 2020 07:00AM Amicus Therapeutics to Announce Third Quarter 2020 Financial Results on November 5, 2020
Oct 12, 2020 07:02AM Amicus Therapeutics (FOLD) Reports Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy
Oct 12, 2020 07:00AM Amicus Therapeutics Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 49th Annual Meeting of the Child Neurology Society
Sep 24, 2020 07:06AM Amicus Therapeutics (FOLD) Receives EMA PRIME Designation for CLN6 Batten Disease Gene Therapy
Sep 24, 2020 07:00AM Amicus Therapeutics Receives European Medicines Agency PRIME Designation for CLN6 Batten Disease Gene Therapy
Sep 3, 2020 07:00AM Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2020
Aug 10, 2020 07:00AM Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
Aug 4, 2020 07:00AM Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference
Jul 28, 2020 07:00AM Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020
Jul 17, 2020 07:33AM Amicus Therapeutics (FOLD) Secures $400 Million Non-Dilutive Debt Financing
Jul 17, 2020 07:31AM Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
Jun 4, 2020 07:00AM Amicus Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
May 8, 2020 07:00AM Amicus Therapeutics Announces Virtual 2020 Annual Meeting of Shareholders
May 7, 2020 07:00AM Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
May 6, 2020 07:00AM UPDATE – Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting
May 5, 2020 07:00AM Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting
Apr 24, 2020 07:00AM Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020
Mar 23, 2020 07:06AM Amicus Therapeutics (FOLD) Reiterates Business Continuity, FY20 Strategic Priorities; Highlights Response to COVID-19 Outbreak
Mar 23, 2020 07:00AM Amicus Therapeutics Confirms Business Continuity, 2020 Strategic Priorities and Announces Proactive Efforts to Support Public Health Initiatives, Patients & Employees
Mar 5, 2020 07:00AM Amicus Opens New Global Research and Gene Therapy Center of Excellence in Philadelphia
Mar 2, 2020 07:00AM Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates
Feb 26, 2020 07:00AM Amicus Therapeutics to Present at the Cowen & Company 40th Annual Health Care Conference
Feb 19, 2020 07:00AM Amicus Therapeutics to Announce Full-Year 2019 Financial Results on March 2, 2020
Feb 7, 2020 07:00AM Amicus Therapeutics Announces Presentations and Posters at 16th Annual WORLDSymposium™ 2020
Jan 13, 2020 07:00AM Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance
Jan 9, 2020 07:09AM Amicus Therapeutics (FOLD) Announces Preliminary 2019 Galafold Revenue, Exceeding Upper End of Prior Guidance
Jan 9, 2020 07:00AM Amicus Therapeutics Announces Preliminary 2019 Galafold Revenue - Exceeding Upper End of Prior Guidance
Jan 7, 2020 07:04AM Amicus Therapeutics (FOLD) Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease
Jan 7, 2020 07:00AM Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-GAA for Pompe Disease
Nov 11, 2019 07:00AM Amicus Therapeutics Announces Third Quarter 2019 Financial Results and Corporate Updates
Oct 30, 2019 07:00AM Amicus Therapeutics to Announce Third Quarter 2019 Financial Results on November 11, 2019
View More Recent Stories View Older Stories